Terumo’s Post

🚀 Breaking Boundaries in Healthcare! 🌐 Exciting news as we gear up to launch a whopping 100,000 Clinical Trials by 2024, propelling us into a new era of healthcare innovation and research advancements! 🏥💡 Here's your sneak peek into this monumental initiative: 🌟 Diverse Impact: 🌈 From pharmaceuticals to medical devices, these trials cover a vast spectrum of healthcare domains. We're set to make waves, addressing critical health challenges and pioneering solutions across the board! 📋 Regulatory Agility: ⚖️ No more bureaucratic hurdles! We're streamlining approvals, ensuring that groundbreaking research gets off the ground faster. Say hello to a future where research moves at the speed of innovation! Contact us: +91 8050276200 Learn more: www.emrti.com #emrti #institute #empowerresearchinstitute #clinicalresearchcertification #HealthcareInnovation #ClinicalTrials2024 #GlobalHealthCollaboration #Teamwork #ResearchAgility #RegulatoryInnovation

💡 Did you know that Edwards Lifesciences is taking part in the HEU-EFS project that has officially launched in Europe?   This @IHIEurope research project will develop a Harmonized Approach to Early Feasibility Studies for Medical Devices in the 🇪🇺. This consortium, involving 22 public and private organizations across Europe, aims to improve the early evidence generation pathway for medical device innovations. The goal is to facilitate access to innovative technologies for patients with unmet needs, increase the attractiveness of the EU for innovators, and support healthcare system efficiencies. Learn more at https://lnkd.in/ewXdnRH2 #HEUEFS #CERGAS #Bocconi #EdwardsLifesciences #IHITransformingHealth #PatientCare #Evidence #Leadership #MedTech #Innovation #EFS #regulatory #ClinicalTrial #Edwards #EdwardsLifesciences

Running a hospital is tough, especially when staying competitive. Breakthrough technology can help, but you need revenue-generating products. The FDA's NTAP program can assist medtech companies in getting their disruptive technologies to market by unlocking additional reimbursement opportunities. Check out this video from #HospitalReview1 that explains the opportunity for CMS Reimbursement NTAP & TPT using an example from Boston Scientific. #HealthcareInnovation #MedicalDevices #NTAP #FDA #HospitalRevenue Watch the video here: https://lnkd.in/g463-9ZE

Terumo goes beyond boundaries — of R&D and production, of regions and functions, inside and outside the company — to further evolve the technologies we have cultivated across decades and develop unprecedented new technologies for the benefit of patients worldwide. At the root of these efforts lies our commitment and corporate mission of contributing to society through healthcare. #NationalTechnologyDay #TechnologyDay

In the face of rapid evolution in the #healthcare industry, Flex stands at the forefront, addressing the diverse challenges faced by today's medical, pharmaceutical, and life sciences companies. From design to advanced manufacturing to global supply chain solutions, Flex enables companies to accelerate time to market, reduce risk, and scale products in regions globally - all with sustainable business practices. With Flex, you're not just delivering cutting-edge technology; you're partnering in a journey toward tomorrow's healthcare breakthroughs. Let's redefine patient care together. Learn how: #HealthcareInnovation #MedicalManufacturing #Innovation

In the face of rapid evolution in the #healthcare industry, Flex stands at the forefront, addressing the diverse challenges faced by today's medical, pharmaceutical, and life sciences companies. From design to advanced manufacturing to global supply chain solutions, Flex enables companies to accelerate time to market, reduce risk, and scale products in regions globally - all with sustainable business practices. With Flex, you're not just delivering cutting-edge technology; you're partnering in a journey toward tomorrow's healthcare breakthroughs. Let's redefine patient care together. Learn how: #HealthcareInnovation #MedicalManufacturing #Innovation

𝘼𝙘𝙘𝙤𝙧𝙙𝙞𝙣𝙜 𝙩𝙤 Polaris Market Research & Consulting , 𝙩𝙝𝙚 𝙜𝙡𝙤𝙗𝙖𝙡 𝙢𝙚𝙙𝙞𝙘𝙖𝙡 𝙚𝙦𝙪𝙞𝙥𝙢𝙚𝙣𝙩 𝙢𝙖𝙞𝙣𝙩𝙚𝙣𝙖𝙣𝙘𝙚 𝙢𝙖𝙧𝙠𝙚𝙩 𝙬𝙖𝙨 𝙫𝙖𝙡𝙪𝙚𝙙 𝙖𝙩 𝙐𝙎𝘿 𝟒𝟑.𝟕𝟐 𝙗𝙞𝙡𝙡𝙞𝙤𝙣 𝙞𝙣 𝟐𝟎𝟐𝟐 𝙖𝙣𝙙 𝙞𝙨 𝙚𝙭𝙥𝙚𝙘𝙩𝙚𝙙 𝙩𝙤 𝙧𝙚𝙖𝙘𝙝 𝙐𝙎𝘿 𝟏𝟏𝟖.𝟎𝟖 𝘽𝙞𝙡𝙡𝙞𝙤𝙣 𝘽𝙮 𝟐𝟎𝟑𝟐, 𝙜𝙧𝙤𝙬𝙞𝙣𝙜 𝙖𝙩 𝙖 𝘾𝘼𝙂𝙍 𝙤𝙛 𝟏𝟎.𝟓% 𝙙𝙪𝙧𝙞𝙣𝙜 𝙩𝙝𝙚 𝙛𝙤𝙧𝙚𝙘𝙖𝙨𝙩 𝙥𝙚𝙧𝙞𝙤𝙙. 𝙈𝙤𝙧𝙚 𝙍𝙚𝙥𝙤𝙧𝙩 𝘿𝙚𝙩𝙖𝙞𝙡𝙨: https://lnkd.in/dAZNKbWv The Asia-Pacific region is poised for substantial growth during the forecast period. Governments in this area are making significant investments in healthcare infrastructure and services. These investments frequently involve the acquisition of #medicalequipment for public healthcare institutions, typically accompanied by maintenance contracts, which are propelling market expansion. 𝙎𝙤𝙢𝙚 𝙤𝙛 𝙩𝙝𝙚 𝙏𝙤𝙥 𝙈𝙖𝙧𝙠𝙚𝙩 𝙋𝙡𝙖𝙮𝙚𝙧𝙨 𝘼𝙧𝙚: Agiliti Alliance Medical Group Aramark BKK B. Braun Melsungen AG BC Technical, Inc. Drägerwerk AG & Co. KGaA Elekta GE HealthCare Medtronic Siemens Healthineers STERIS #MedicalEquipmentMaintenanceMarket #MedicalEquipmentMaintenanceIndustry #MedicalEquipmentMaintenance #marketresearch #marketresearchreports #polarismarketresearch

Today, on National Innovation Day, we praise the remarkable strides made in the pharmaceutical and healthcare sector. Innovation is the driving force behind advancements in medicine, paving the way for groundbreaking treatments and improved patient outcomes. As professionals in this dynamic field, let's take a moment to reflect on the transformative impact of innovative approaches in healthcare. From precision medicine to revolutionary therapies, the relentless pursuit of innovation continues to redefine the landscape of medical science. It’s a testament to the collaborative efforts of researchers, clinicians, and industry leaders who dedicate themselves to pushing the boundaries of what's possible. As we acknowledge the achievements of the past, let's also look forward to the future, where ongoing innovation holds the promise of addressing unmet medical needs, enhancing accessibility, and ultimately improving the quality of life for patients worldwide. Here's to the innovators, the trailblazers, and the visionaries shaping the future of healthcare. 🌟 #NationalInnovationDay #HealthcareInnovation #PharmaInnovation #MedicineAdvancements #MedicalResearch #InnovationInHealthcare

In the face of rapid evolution in the #healthcare industry, Flex stands at the forefront, addressing the diverse challenges faced by today's medical, pharmaceutical, and life sciences companies. From design to advanced manufacturing to global supply chain solutions, Flex enables companies to accelerate time to market, reduce risk, and scale products in regions globally - all with sustainable business practices. With Flex, you're not just delivering cutting-edge technology; you're partnering in a journey toward tomorrow's healthcare breakthroughs. Let's redefine patient care together. Learn how: #HealthcareInnovation #MedicalManufacturing #Innovation

Medical device contract manufacturing is a growing market supported by several long-term tailwinds, including an aging population, rising rate of chronic disease, higher focus on early diagnosis and treatment, and increasing medical innovation. In addition, medical device OEMs and biotech companies have an expanding need for outsourced development, pre-production, manufacturing, and post-production services as they focus more on their core competencies.    Our Healthcare & Life Sciences Group recently saw these themes on display at #MEDICA2023 and #COMPAMED2023, two events covering the future of healthcare and medical tech. “In the post-COVID world, the medical device contract manufacturing segment is normalizing and experiencing rising optimism thanks to resolved supply chain issues and reduced inventory stocking,” says director Stephan Döring. “However, due to tight OEM and biotech budgets, leading CDMOs in the space are becoming more careful in evaluating project risks, particularly for projects with a large development share that only monetizes during the serial production phase.”    In this dynamic environment, the most innovative and sought-after CDMOs are also staying ahead of the curve on trending topics like sustainability, microtechnology, robotics, and digitization. The CDMOs with end-to-end customized capabilities from concept to finished goods can partner with OEMs for their most complex products, saving costs and increasing throughput for their customers by establishing more effective, automated production lines.    To discuss M&A opportunities across medical device contract manufacturing, please contact our senior professionals: https://lnkd.in/eXnFj4dz Dr Julian Feneley, Tyler Bradshaw, Stephan Döring, Andrey Dvorkin, Taylor Will, Daniel Stelbrink